The Alveolar Rhabdomyosarcoma Treatment Market in North America is supported by advanced healthcare infrastructure, increasing awareness of pediatric cancers, and ongoing research into innovative oncology therapies. The region benefits from specialized pediatric cancer centers, established clinical trial networks, and significant investments in targeted therapies, immunotherapy, and...